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a  b  s  t  r  a  c  t
Existing  evidence  on  the  relationship  between  R&D  intensity  and  ﬁrm  survival  is  varied  and  often  con-
ﬂicting.  We  argue that  this  may be  due  to overlooking  R&D  scale  effects  and complementarity  between
R&D  intensity  and  market  concentration.  Drawing  on  Schumpeterian  models  of  competition  and  inno-
vation,  we address  these  issues  by  developing  a formal  model  of  ﬁrm  survival  and  using  a  panel  dataset
of  37,930  of  R&D-active  UK  ﬁrms  over  1998–2012.  We  report  the following  ﬁndings:  (i)  the relationship
between  R&D  intensity  and  ﬁrm  survival  follows  an inverted-U  pattern  that  reﬂects  diminishing  scale
effects;  (ii)  R&D intensity  and  market  concentration  are  complements  in that  R&D-active  ﬁrms  have
longer  survival  time  if they  are  in  more  concentrated  industries;  and  (iii)  creative  destruction  as  proxied
by median  R&D  intensity  in the  industry  and  the  premium  on business  lending  have  negative  effects  on
ﬁrm  survival.  Other  ﬁndings  concerning  age,  size,  productivity,  relative  growth,  Pavitt  technology  classes
and  the macroeconomic  environment  are  in  line  with  the  existing  literature.  The  results  are  strongly  or
moderately  robust  to different  samples,  stepwise  estimations,  and  controls  for  frailty  and  left  truncation.
© 2016  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Existing work has so far identiﬁed a wide range of consistent
empirical patterns on ﬁrm entry and exit, of which the following
are cited most often: (i) contemporaneous entry and exit rates are
highly and positively correlated; (ii) ﬁrm size and age are corre-
lated positively with survival; (iii) small ﬁrms that survive tend to
grow faster than larger ﬁrms; and (iv) younger ﬁrms have a higher
probability of exiting, but those that survive tend to grow faster
than older ﬁrms (Geroski, 1995; Klette et al., 2004).
In contrast, ﬁndings on the relationship between innovation
and survival are varied and often conﬂicting. This is the case with
respect to both input measures such as investment in research and
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ES/K004824/1. We  thank our funders for their generous support. We  also thank
the participants of the workshop held on 4 June 2015 for their engagement and
comments. The views expressed here are those of the authors, who are responsible
for any errors or omissions.
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development (R&D) and output measures such as patents, trade-
marks or product/process innovations. To understand the causes
of heterogeneity, we propose and test a Schumpeterian model of
knowledge production, ﬁrm value and survival. The model yields
three testable hypotheses: (i) the effect of R&D intensity on ﬁrm
survival is subject to diminishing returns, whereby survival time
increases at diminishing rates and eventually falls as R&D intensity
exceeds an optimal level; (ii) R&D intensity and market concen-
tration are complements in that a given level of R&D intensity is
associated with longer ﬁrm survival in more concentrated indus-
tries; and (iii) higher levels of R&D intensity in the industry and
higher premiums on business lending are associated with shorter
survival time.
The article is organised as follows. Section 2 provides a brief
review of the related literature. In Section 3, we propose a survival
model informed by Schumpeterian models of competition, innova-
tion and ﬁrm performance. In Section 4, we  discuss our data and
estimation methodology. In Section 5, we estimate our model with
a lognormal duration estimator chosen on the basis of Akaike and
Bayesian information criteria and Cox-Snell residuals. We  conclude
by summarising the main ﬁndings and their implications for future
research.
http://dx.doi.org/10.1016/j.respol.2016.04.007
0048-7333/© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2. Related literature
Theoretically, investment in R&D can enhance a ﬁrm’s survival
as a result of productivity gains (Griliches, 1979) and/or increased
market power (Aghion et al., 2014). However, R&D investment
entails risks and is a major source of stochastic productivity shocks
that generate both entry and exit (see, for example, Jovanovic, 1982,
1994; Hopenhayn, 1992; Ericson and Pakes, 1995). Secondly, the
productivity of R&D projects tends to diminish with size, partic-
ularly when ﬁrms are closer to the technology frontier (Pammolli
et al., 2011; DiMasi and Grabowski, 2012). Furthermore, there is
evidence that the patents-to-R&D ratio tends to fall as R&D inten-
sity increases (Kortum, 1993). Finally, Czarnitzki and Toole (2013)
report that larger R&D projects are usually observed in highly
concentrated industries and this may  be due to higher market
uncertainty associated with larger projects.
Given such complexities in the relationship between R&D inten-
sity and ﬁrm performance, it is not surprising to observe varied and
often conﬂicting ﬁndings on the relationship between R&D inten-
sity and survival. Heterogeneity is evident irrespective of whether
the explanatory variable is an output or input measure of inno-
vation. Some studies using an output measure (e.g., patent count,
trademarks, number of product or process innovations) report a
positive and signiﬁcant relationship between innovation and ﬁrm
survival among US ﬁrms (Audretsch, 1991), Dutch manufacturing
ﬁrms (Ceﬁs et al., 2005, 2006), and UK ﬁrms (Helmers et al., 2010).
However, several studies also report insigniﬁcant or even neg-
ative effects. Audretsch (1995) use the same dataset as Audretsch
(1991) and report that small-ﬁrm innovation rate has no effect on
survival when ﬁrm characteristics such as age and size are con-
trolled for. Similarly, Giovannetti et al. (2011) report that product
or process innovation has no effect on survival among Italian ﬁrms.
Using Australian data, Jensen et al. (2006) and Buddelmeyer et al.
(2010) report interesting ﬁndings: whereas patent applications as a
measure of high-risk innovation are associated with lower survival
rates, trademark applications as a measure low-risk innovation lead
to higher survival rates.
Conﬂicting ﬁndings have been reported with respect to survival-
effects of R&D intensity too. Of these, Esteve-Pérez et al. (2004)
and Esteve-Pérez and Man˜ez-Castillejo (2008) estimate Cox pro-
portional hazard (CPH) and parametric survival models and report
a positive effect in Spanish ﬁrm data. A similar ﬁnding is reported
by Li et al. (2010), who estimate a CPH model with data on 870
software companies and report that the ﬁrm’s R&D capital expen-
ditures on labs and equipment are associated with lower hazard
rates.
In contrast, a number of studies report mixed, insigniﬁcant or
negative effects. Mahmood (2000) estimates a log-logistic model
of survival with US data on start-up companies from 1976 to 1986.
Splitting the sample by industry and technology level, he reports
17 estimations in total − 8 for low-tech, 6 for medium-tech, and 3
for high-tech industries. He ﬁnds that R&D intensity have insigniﬁ-
cant effects in 11 out of 17 estimations. Of the six signiﬁcant effects,
four are positive and two are negative; and the estimates are consis-
tently smaller in magnitude as one moves from low-tech through
medium-tech to high tech industries.
A similar set of ﬁndings is reported by Børing (2015), who
estimates a competing-hazard model with Norwegian ﬁrm data.
The R&D intensity, measured as share of R&D personnel in total
employment, is insigniﬁcant among energy, materials, services and
scale-intensive industries, and positive only in the science-based
industry and specialised suppliers of technology. When all ﬁrms are
pooled together, R&D intensity increases hazard rates, i.e. it reduces
survival time. Finally, a negative relationship between survival and
R&D expenditures is reported in Wilbon (2002), who estimates a
logit regression with data on high-tech US ﬁrms that went public
in 1992.
Two  working papers report non-linear effects. Sharapov et al.
(2011) estimate a CPH model using UK data for manufacturing
ﬁrms and report an inverted-U relationship between R&D intensity
(R&D/turnover ratio) and hazard rates, although this relationship
was not robust across samples. In contrast, Zhang and Mohnen
(2013) report an inverted-U relationship between R&D intensity
(R&D/sales ratio) and survival rates of Chinese start-ups.
It can be argued that heterogeneous ﬁndings may  be due to
different samples and estimation methods. Nevertheless, such dif-
ferences do not seem to have generated varied and often conﬂicting
ﬁndings on survival effects of other ﬁrm-, industry- or macro-
level factors. For example, survival is reported to increase with age
and size, albeit the relationship may  be non-linear in some cases
(Geroski, 1995; Klette et al., 2004). Productivity or growth are also
reported to have usually positive effects on survival (Ceﬁs et al.,
2005; Mata et al., 1995; Agarwal, 1997). There is also consistency in
reported effects of industry-level factors such as industry technol-
ogy class (Pavitt, 1984), entry rates, and industry growth; as well as
macro-economic indicators such as currency appreciation, lending
rates or economic crisis periods (for a review, see Manjón-Antolín
and Arauzo-Carod, 2008).
Therefore, we  argue that the heterogeneity in the evidence base
may  be a symptom of model misspeciﬁcation. One potential source
of speciﬁcation bias is the absence of control for R&D scale effects,
which may  matter for several reasons. First, the riskiness of R&D
investments may  increase with R&D intensity (Ericson and Pakes,
1995; Czarnitzki and Toole, 2013). Secondly, R&D investment may
not generate commercially successful innovation outcomes and/or
the ﬁrm may  fail to diversify its revenue streams at the same pace as
its investment in innovation (Fernandes and Paunov, 2015). Third,
a given level of own R&D intensity may  have different effects on
ﬁrm survival depending on R&D intensity in the ﬁrm’s industry
(Schumpeter, 1942; Audretsch et al., 2000; Fritsch et al., 2006;
Aghion et al., 2014).
Model speciﬁcation bias could also arise from the absence of
control for complementarity or substitution between R&D inten-
sity and market structure. Such control is justiﬁed given the
insights from the industrial organisation literature on innovation.
As indicated by Gilbert (2006), a given level of market concen-
tration induces different levels of innovation inputs or outputs −
depending on the initial level of concentration. Also, a given level
of competition may  induce different levels of R&D investments
depending on creative destruction in the industry (Aghion et al.,
2005, 2009, 2014). Given these insights, it is necessary to control not
only for direct effects of R&D intensity and market concentration
separately, but also for their interactive effects.
3. Model of R&D intensity and survival
Drawing on Schumpeterian models of competition, innovation
and growth, we  propose a survival model that takes account of R&D
scale effects, complementarity/substitution between R&D inten-
sity and market concentration, creative destruction in the industry,
and the risk premium on business lending. The model shares the
Schumpeterian view that: (a) R&D investments are motivated by
the prospects of innovation rents; and (b) growth is a function of
creative destruction that involves the replacement of old technolo-
gies by new innovations (Aghion et al., 2014).
The model has ﬁve main pillars, four of which are standard com-
ponents in Aghion et al. (2014): (i) a knowledge production function
with two  inputs (number of scientists and knowledge stock) and
constant returns to scale; (ii) a cost function for knowledge pro-
duction, with costs increasing in the wage rate and the number of
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knowledge production lines; (iii) normalised average value of the
knowledge production line, which depends on gross proﬁts, the
cost of innovation, the discount rate for R&D projects and the rate
of creative destruction in the industry; and (iv) a ﬁrm-value func-
tion that depends on the number of knowledge production lines,
output and the normalised average value of the knowledge produc-
tion line. The ﬁfth component represents a digression from Aghion
et al. (2014) and consists of equating the ﬁrm value in (iv) with a
market-based value, which we assume to follow a Wiener process
until the ﬁrm exits the market due to liquidation (McDonald and
Siegel, 1985). As we demonstrate in Appendix A, the model speciﬁes
survival time as follows:
E [t] ∼= 2
2 − 2
[
ln (k) + ln
(
Yt
V0
)
+ ln − wz

i
 + x − zi
]
(1)
Here, E[t] is expected survival time, which increases with the
number of innovation lines (k), the ratio of output to initial ﬁrm
value (Yt /V0) and gross proﬁts (). However, the relationship
between survival time and innovation intensity is non-linear: sur-
vival time increases with the linear term (zi) in the denominator,
but decreases with the non-linear term (z
i
) in the numerator.1 In
Appendix A, we demonstrate that the extremum in the relationship
between innovation intensity and survival time is a local maximum,
where the marginal cost of investment in innovation is equal to
the normalised value of the knowledge production line. After that
point, a further increase in innovation intensity diminishes ﬁrm
value (and survival time) as it adds to the cost of innovation more
than it adds to ﬁrm value.
The model allows for two further predictions. First, survival time
increases with higher gross proﬁts, , at each level of innovation
intensity.2 Stated differently, R&D intensity and gross proﬁts are
complements in that R&D-active ﬁrms with higher gross proﬁts
enjoy longer survival times compared to competitors with the same
level of R&D intensity but lower levels of gross proﬁts. Hence, and to
the extent that proﬁts and market concentration are correlated pos-
itively, the model allows for predicting that R&D-active ﬁrms would
survive longer if they are located in more concentrated industries.
Second, higher discount rates () for R&D projects or higher rates
of creative destruction in the industry (x) reduce ﬁrm survival pro-
vided that ( + x) > zi.3 Higher discount rates reduce survival time
due to their negative effect on the normalised value of the knowl-
edge production line, which is adjusted for expected future risks.4
Survival time also decreases with the rate of creative destruction
because the latter accelerates the rate at which the ﬁrm’s own
innovative technology becomes obsolete (Aghion et al., 2014).
Hence, our testable hypotheses can be stated as follows:
H1. The effect of R&D investment on survival is subject to dimin-
ishing scale effects, whereby survival time increases with R&D
intensity at decreasing rates and eventually falls as R&D intensity
exceeds an optimum level.
H2. R&D intensity and market concentration are complements in
that a given level of R&D intensity is associated with longer survival
times when R&D-active ﬁrms are in more concentrated industries.
1 Of the remaining variables,  is the volatility and  is the drift parameter in the
Wiener process. In line with existing empirical ﬁndings, we  assume that  <
√
2
(see Appendix A).
2 See Appendix A.
3 See Appendix A.
4 In Schumpeterian models of innovation, higher discount rates are conducive to
lower innovation intensity (Aghion et al., 2014). This adverse effect on innovation
intensity may  be an additional channel through which higher discount rates reduce
survival time. However, our focus here is on the survival effects of the discount rate
through ﬁrm value, holding the innovation intensity constant (see Appendix A).
H3. Survival time is negatively related to the rate of creative
destruction in the industry and the discount rate, provided that
the sum of the two is larger than the ﬁrm’s innovation intensity.
To test for H1,  we  approximate innovation intensity (zi) with a
second-order polynomial of R&D intensity (RD int), deﬁned as ratio
of ﬁrm’s total R&D to turnover, such that zi ≈ aRD int2 + bRD int.5
Given the logarithmic functional form in (9), we also use the Taylor
approximation of ln (RD int + 1) ≈ RD int if 0 < RD int < 1. The R&D
intensity of more than ninety percent of ﬁrms in the dataset satis-
ﬁes this condition. We check whether the results are sensitive to
different values for the maximum level of R&D intensity by esti-
mating the model with ﬁve different cut-off points, including top
R&D intensity less than one and top R&D intensity below the 98th,
97th, 95th, and 75th percentiles of the R&D intensity distribution.
To test for H2,  we use market concentration as a proxy for
unobserved proﬁts. This approximation is justiﬁed on the basis of
theoretical and empirical ﬁndings that ﬁrm proﬁt and market con-
centration are correlated positively in different industries (Bain,
1951; Peltzman, 1977; Tirole, 1988; Berger 1995; Slade 2004).
Finally, to test for H3 we  measure the creative destruction rate
in the industry by the median of R&D intensity at 3-digit SIC level.
Given that the discount rate for each ﬁrm is not known, we use
the business lending premium as a proxy. The latter reﬂects the
risk premium on lending to private corporations compared to the
risk-free Treasury bill interest rate.
Table 1 below provides a summary of the main covariates of
interest and a range of ﬁrm-, industry- and macro-level variables
controlled for. The choice of each covariate and its expected effect
on survival are informed by the relevant literature indicated in the
last column.
Covariates (1) and (2) enable us to test if the relationship
between R&D intensity and ﬁrm survival is subject to increasing
or diminishing scale effects. So far, only two  working papers have
tested for non-linear relationship between R&D intensity and sur-
vival (Sharapov et al., 2011; Zhang and Mohnen, 2013). However,
both studies lack a theoretical model that provides an optimising
foundation for the relationship. In addition, they report conﬂict-
ing ﬁndings: whereas the former report an inverted-U relationship
between R&D intensity and hazard rates in UK data, which is the
opposite of what we  predict, the latter reports an inverted-U rela-
tionship between R&D intensity and survival rates for Chinese
start-ups, which is in line with our prediction. Finally, the ﬁndings
in both studies require further robustness checks before they can
be upheld.
Covariate 3 allows for testing whether R&D intensity and mar-
ket concentration are complements or substitutes. To the best of
our knowledge, this is the ﬁrst study that addresses this issue. As
indicated above, we predict complementary effects as both R&D
intensity and market concentration have an ‘escape competition
effect’ (Aghion et al., 2014).
We  control for covariates four and ﬁve to test if survival time is
negatively related to creative destruction and the premium on busi-
5 R&D intensity is a common input measure of innovation as it reﬂects the propor-
tion of output devoted to innovation (Aghion et al., 2005, 2014). For approximation
of the innovation input with a polynomial function of R&D intensity, see Lokshin
et  al. (2008). For other applications of the polynomial functions to other inputs, see
Fuss et al. (1978) and Basant and Fikkert (1996).
6 Pavitt1 consists of ﬁrms in science-based industries such as chemicals, ofﬁce
machinery, precision, medical and optical instruments industries, ICT. Pavitt2
includes specialized suppliers of technology−mechanical engineering industries,
manufacturers of electrical machinery, equipment, etc. Pavitt3 includes scale-
intensive industries such as pulp and paper, transport vehicles, mineral oil reﬁning
industries. Pavitt4 includes industries dominated by technology suppliers, e.g.,
textiles & clothing, food & drink, fabricated metals. Finally, Pavitt5 consists of unclas-
siﬁed industries.
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Table  1
Covariates and expected effects on ﬁrm survival.6
Covariate Description and (expected effect) Related literature
Covariates of main interest
1. R&D intensity Logarithm of R&D expenditures as proportion
of turnover (+)
Mahmood (2000), Esteve-Pérez et al. (2004),
Børing (2015) and Ericson and Pakes (1995)
2. R&D int. sq. Squared logarithm of R&D intensity (−) Aghion et al. (2001, 2014), Ericson and Pakes
(1995), Sharapov et al. (2011) and Zhang and
Mohnen (2013)
3. (R&D int.)*(HI) Product of R&D intensity and HI (+) Aghion et al. (2001, 2014), Ericson and Pakes
(1995)
4. Median R&D intensity in industry Proxy for creative destruction. The median
R&D intensity is at 3-digit industry level (−)
Schumpeter (1942), Aghion et al. (2001, 2014),
Audretsch (1991) and Audretsch (1995)
5. Lending premium Business lending rate minus government bond
rate, obtained from Bank of England data (−)
Holmes et al. (2010) and Liu (2004)
6 & 7. Herf. Index (HI) and its square Herﬁndahl-Hirschman index (HI) calculated at
3-digit industry level (+ /−; −/ +)
McCloughan and Stone (1998), Baldwin and
Raﬁquzzaman (1995), Wagner (1994) and
Fernandes and Paunov (2015)
Other ﬁrm-level covariates
8.  Firm growth relative to industry Growth of ﬁrm’s deﬂated turnover minus
3-digit industry median growth (+)
Ceﬁs and Marsili (2005), Mata et al. (1995) and
Agarwal (1997)
9.  Fast growth in last 3 years before exit Dummy  variable = 1 if the ﬁrm grows faster
than 3-digit industry median growth for three
consecutive years before exit (−)
New. Reviewer recommendation to test for
overstrained growth strategy
10.  Age Logarithm of ﬁrm age in years (+) Hopenhayn (1992), Ericson and Pakes (1995),
(Geroski, 1995), Ceﬁs and Marsili (2005), Doms
et al. (1995) and Disney et al. (2003)
11. Age squared Squared logarithm of age (−) Ericson and Pakes (1995), Ceﬁs and Marsili
(2005) and Evans (1987)
12. Size Logarithm of employees headcount (+) Hopenhayn (1992), Ericson and Pakes (1995),
(Geroski, 1995), Ceﬁs and Marsili (2005), Doms
et al. (1995) and Disney et al. (2003)
13. Size squared Squared logarithm of employees (−) Bhattacharjee et al. (2009) and Ceﬁs and
Marsili (2005)
14.  Local unit Indicates number of live local unit in
multi-plant ﬁrm (+ /−)
Audretsch (1995) and Fernandes and Paunov
(2015)
15. Labour productivity Deﬂated turnover per employee (+) Audretsch (1991), Ericson and Pakes (1995)
and Griliches and Regev (1995)
16. Civil R&D Dummy  variable indicating that ﬁrm is
engaged in civil R&D only; ﬁrms engaged in
defence R&D are excluded (+ /−)
New. To test if survival rates differ between
ﬁrms engaged in civil and defence R&D
17.  UK-owned Dummy  variable indicating that the ﬁrm is
UK-owned (+ /−)
Sharapov et al. (2011)
Industry covariates
18. Pavitt technology classesa Four dummy variables for 4 Pavitt
classes−excluded category is Pavitt class
dominated by technology suppliers (+ /−)
Pavitt (1984), Agarwal and Audretsch (2001)
and Ceﬁs and Marsili (2005)
19.  Industry dummies 2-digit industry dummies Usual practice to control for industry effects
Macroeconomic factors
20. Crisis year Dummy  equal 1 for the Asian crisis year of
1998; dot.com bubble crisis of 2001; and the
recent ﬁnancial crisis in 2008 (−)
Not tested before; but Bhattacharjee et al.
(2009) report higher hazard rates in periods of
volatility
21.  Effective exchange rate Average effective exchange rate deﬁned
against a basket currencies−an increases
indicates appreciation (−)
Bhattacharjee et al. (2009) and Goudie and
Meeks (1991)
a Pavitt technology classes are from Pavitt (1984), as revised slightly by Bogliacino and Pianta (2010).
ness lending. We  measure creative destruction with the median
(rather than mean) of R&D intensity in the industry because R&D
intensity is known to be highly skewed. Both Audretsch (1991) and
Audretsch (1995) report that industry-level R&D intensity has a
negative effect of survival time. Similarly, both Holmes et al. (2010)
and Liu (2004) also report a negative relationship between inter-
est rates and ﬁrm survival. The contribution here is to demonstrate
that these covariates are integral to the formal survival model we
propose.
Covariates six and seven enable us to test for the direct effect of
market concentration on survival. McCloughan and Stone (1998)
and Baldwin and Raﬁquzzaman (1995) ﬁnd a signiﬁcant posi-
tive relationship between market concentration and ﬁrm survival.
However, Mata and Portugal (1994) and Wagner (1994) report
insigniﬁcant effects. The aim here is to verify whether market con-
centration affects survival after controlling for its interaction with
R&D intensity.
Covariate eight measures the difference between ﬁrm growth
and the median growth in the 3-digit SIC industry level. As such,
it reduces heterogeneity in ﬁrm growth by correcting for indus-
try ﬁxed effects. On the other hand, the covariate nine controls
for the fast growth in the last 3 years before exit in form of a
dummy  variable that is equal to 1 if the ﬁrm grows faster than
the 3-digit industry median for three consecutive years before exit.
It is intended to verify if fast growth over a sustained period before
exit may  be a sign of an overstained growth strategy.7
We control for a wide range of other variables tested widely
in the literature. The ﬁrm-speciﬁc covariates include age and size,
7 We thank one of our anonymous reviewers for drawing our attention to the
need for reducing heterogeneity in the ﬁrm-speciﬁc growth variable, and to test for
the  presence of overstrained growth before exit. We  are solely responsible for any
error or omission in implementing reviewers’ recommendations.
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domestic ownership, number of plants (local units), and whether
the ﬁrm is engaged in civil R&D as opposed to those engaged in
defence-only or civil and defence R&D. We  also control for non-
linearity in age and size to verify if ﬁrms experience a reversal in
fortunes once they are beyond an ‘optimal’ age or size. In addition
to industry dummies, we control for Pavitt technology classes to
test if the technology type matters for survival after controlling for
R&D intensity (see Agarwal and Audretsch, 2001; Ceﬁs et al., 2005).
To take account of the macro-economic environment, we  use the
effective exchange rate as a measure of international competitive-
ness and the years of ﬁnancial crisis as indicators of downswings.
4. Data and methodology
Our dataset is constructed by merging two UK ﬁrm-level
databases: the Business Structure Database (BSD) and the Business
Expenditure on Research and Development (BERD).8 BSD consists
of annual snapshots from the Interdepartmental Business Reg-
ister (IDBR), which includes all ﬁrms registered for VAT and/or
PAYE (pay-as-you-earn) purposes. It provides ﬁrm-level demo-
graphic information, together with unique ﬁrm identiﬁers (entref)
and local-unit (plant) identiﬁers (luref) (ONS, 2016).
In BSD, ﬁrm exit is recorded as the year in which the ﬁrm dis-
appears due to mergers, acquisitions, liquidation or bankruptcy.
If the ﬁrm disappears due to mergers or acquisitions, its entref
disappears but its luref remains the same. On the other hand, if
the ﬁrm disappears due to liquidation or bankruptcy, both entref
and luref disappear from the Register. Therefore, it was possible
to differentiate between exits due to corporate market control and
liquidation/bankruptcy. We  identiﬁed the former by checking if the
ﬁrm’s local-unit reference survived its enterprise reference. If this
condition holds, the ﬁrm is excluded from the analysis. Hence, the
survival analysis here is based on ﬁrm exits due to liquidation or
bankruptcy.
Due to recording errors, some ﬁrms remain in the IDBR for sev-
eral years with zero employment and turnover. We  have corrected
for such anomalies by constructing our own exit year, which is the
earliest of the death year recorded by the ONS or the ﬁrst year when
the ﬁrm employment and turnover are zero for 3 consecutive years.
The number of ﬁrms affected by this correction was  147. Another
anomaly in the BSD concerns incorrectly recorded birth years. Firms
that appeared in the ﬁrst Business Register in 1973 were given a
birth year of 1973 despite the fact that most of them had existed
before 1973. After excluding the ﬁrms with incorrect birth years,
the number of remaining ﬁrms is 39,846.
BERD consists of repeated annual surveys with stratiﬁed sam-
pling of ﬁrms known to be R&D-active.9 The most R&D-intensive
400 ﬁrms receive a long questionnaire, with detailed questions on
R&D types and sources of funding. Other ﬁrms receive a short ques-
tionnaire with questions on total, intramural and extramural R&D
only. Missing data is imputed using other sources such as R&D Tax
Credit returns or Annual Business Surveys (ONS, 2015).
We  merged BERD with BSD, using the unique enterprise iden-
tiﬁer (entref).10 We  omitted 1773 ﬁrms with anomaly entrefs,
obtaining a merged set of 38,113 ﬁrms born in 1974 or after. We
8 The standard disclaimer applies: the use of these data does not imply the
endorsement of the data owner or the UK Data Service at the UK Data Archive in
relation to the interpretation or analysis of the data. This work uses research datasets
which may not exactly reproduce National Statistics aggregates.
9 The stratiﬁed sample consists of about 400 R&D-intensive ﬁrms (sampled 1:1);
size-band2 ﬁrms (with 100–399 employees) sampled 1:5 and size-band3 ﬁrms (with
0–99 employees) sampled at a rate of 1:20. Firms covered in BERD account for about
80% of the business R&D expenditures in the UK (ONS, 2012).
10 It must be noted that the time dimension of our data (1998–2012) corresponds
to  the rise of the Internet. As such, our ﬁndings may  be reﬂecting period-speciﬁc
checked the distribution of R&D intensity for skewness.11 We  have
established that the 99th percentile for R&D intensity is several
times the turnover. To minimise the effect of such suspicious out-
liers, we excluded ﬁrm/year observations in the top 1% of the R&D
intensity distribution. Hence, our estimation sample consists of
37,930 ﬁrms with 185,094 ﬁrm/year observations.12
The annual entry and exit rates, together with associated
changes in employment and total R&D expenditures are reported
in a Data in Brief article.13 Results indicate that: (i) overall exit rate
(1.9%) is smaller than the entry rate (4%); (ii) total number of jobs
created by entrants is greater than job destruction due to exits;
and (iii) total R&D investment by entrants is higher than that of
exiters. However, after the onset of the ﬁnancial crisis, exit rates
have been higher or equal to entry rates; and net employment and
R&D expenditures have been negative for at least two  years.
We also checked the correlations between entry and exit rates
at 2-digit industry level, with and without correction for indus-
try ﬁxed effects (Dunne et al., 1988; Disney et al., 2003). The
results indicate that both uncorrected and corrected entry and exit
rates are highly and positively correlated only contemporaneously.
Stated differently, periods of high (low) entry are also periods of
high (low) exit − irrespective of whether industry-speciﬁc tech-
nological conditions are taken into account. This ﬁnding points
out to absence of a ‘sorting effect’ in UK ﬁrm dynamics, whereby
the lower-quality of the marginal entrant in the period of above-
average entry increases the exit rate in the subsequent period
(Disney et al., 2003).
Given these data characteristics, we follow a sequential esti-
mation strategy. First, we  provide nonparametric survival time
estimates, using the Kaplan-Meier estimator:
S (t) =
∏
j<t
Nj − Di
Nj
(2)
where t is time, Nj is the number of ﬁrms at risk at time j, and
Dj is the number of failures (‘exits’) at time j. The non-parametric
estimates compare ﬁrm/year categories based on R&D intensity and
market concentration (Herﬁndahl index) quartiles. We verify the
equality of the non-parametric survival estimates using Wilcoxon,
Tarone-Ware, Peto-Peto and Logrank tests.
Second, we estimate a Cox proportional hazard model, where
the distribution of the initial hazard is non-parametric and the base-
line hazard function h0(t) for the jth ﬁrm shifts proportionately with
each covariate in X. Another property of the model is that the haz-
ard ratio for different ﬁrms is time-invariant. We reject the Cox
model because it fails the Schoenfeld (1982) residuals tests of the
proportionality assumption. We  have also tested for time-invariant
effects, which we had to reject as the interactions of the covariates
with time came out statistically signiﬁcant.
As a result, we turn to parametric models, where survival can be
estimated in proportional hazard (PH) or accelerated failure time
(AFT) metrics:
h(tj) = h0 (t) exp(Xjˇ) (3-PH)
dynamics in innovation. This is an issue worth investigating by using two  compara-
ble samples over different periods, but this is beyond the scope of this paper.
11 High level of skewness in R&D intensity is a well-known feature, predicted by
both stochastic and Schumpeterian models of R&D investment (Klette et al., 2004;
Aghion et al., 2014). Fig. A1 in the Appendix A presents the kernel density plot for
R&D intensity in our sample.
12 We conduct a range of sensitivity checks to establish if parameter estimates
are  sensitive to the level of top R&D intensity excluded from the analysis − see
Tables A2 and A3 in the Appendix A.
13 See Data in Brief, xx(x), xxx (details to be completed after approval by Data in
Brief  editors.)
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logtj = Xi  ˇ + zj (3-AFT)
In Eq. (3-PH), h(tj) is the hazard rate of jth ﬁrm; h0 (t) is
the baseline hazard rate whose distribution depends on ancillary
parameter(s) to be estimated; Xj is a vector of covariates that affect
the hazard rate; and  ˇ is a vector of coefﬁcients to be estimated. In
Eq. (3-AFT), logtj is logarithm of survival time of jth ﬁrm; Xj and ˇ
are as deﬁned above; and zj is the error term with a density function
f(t).
We estimate four non-nested models with different ancillary
parameters: exponential, Weibull, Gompertz, and log-normal. We
have chosen the optimal model using the minimum Akaike (AIC)
and Schwartz (Bayesian) information criteria (BIC), and the ﬁt level
in the Cox-Snell residuals plots. Both sets of criteria favoured the
log-normal model.14
We  estimate the model using covariates in Table 1 with and
without controlling for left truncation and frailty (unobserved het-
erogeneity). Left truncation occurs because we do not observe some
ﬁrms before the start of the analysis time in 1998 even though such
ﬁrm may  have existed in the past. To address this issue, we esti-
mated the model with ﬁrms born in 2001 and thereafter to verify
if the results are sensitive to controlling for left truncation. We  also
estimated the model with unshared frailty to verify if the variance
of the frailty coefﬁcient () is statistically different than zero. If
the variance of the frailty coefﬁcient approaches zero, i.e., if het-
erogeneity among survivors is insigniﬁcant, the model with frailty
reduces to a survival model without frailty regardless of the frailty
distribution (Box-Steffensmeier and Bradford, 2004). The signiﬁ-
cance of the frailty variance () is tested with likelihood-ratio tests,
where the null hypothesis is zero variance. For frailty, we  choose
the ﬂexible gamma  distribution.15
The log-normal model is suitable for right-censored data, where
subjects may  be still alive at the end of the analysis period. This is
ensured by deﬁning the initial time, the end of the analysis time
and the failure (exit) event. In addition, it is appropriate for data
exhibiting delayed entry, gaps, time-varying covariates, or multiple
failures (Blossfeld et al., 1989; Cleves et al., 2008). Finally, param-
eter estimates are elasticities of the survival time with respect
to covariates if the latter are expressed in logarithms or semi-
elasticities if they are expressed in levels (Ceﬁs et al., 2005).
4.1. Results
First, we present non-parametric estimations of the survival
function (Fig. 1). In summary, non-parametric results indicate the
following: ﬁrms with above-median R&D intensity (in the 3rd and
4th quartiles) have lower survival rates than those with below-
median R&D intensity (in the 1st and 2nd quartiles); and ﬁrms in
the bottom quartile of the market concentration have lower sur-
vival rates compared to the rest. In addition, the survival rate of
the ﬁrms in the top quartile of the market concentration remains
higher than all other quartiles as time increases. The Log-rank,
Wilcoxon, Tarone-Ware and Peto-Peto tests indicate that the differ-
ences between survival rates are signiﬁcant in both cases.
However, one should not read too much into non-parametric
estimates as they are not conditioned on ﬁrm, industry and macroe-
conomic indicators that affect survival. Therefore, we turn to
parametric estimations based on summary statistics in Table A1
14 See Fig. A2 in the Appendix A, where the hazard function for the lognormal model
follows the 45◦ line very closely, except for large values of time. However, those of
other parametric models (exponential, Weibull and Gompertz) deviate from the 45◦
line signiﬁcantly and the deviation increases with time.
15 The choice is informed by ﬁndings indicating that the distribution of hetero-
geneity among survivors converges to a gamma distribution rapidly (Abbring and
van  Den Berg, 2007: 145).
in Appendix A, reported for the full sample and for surviving and
exiting ﬁrms separately. One evident pattern in Table A1 is that
the distribution of R&D intensity is strongly skewed to the right
– with skewness measures of 6.7, 7.7 and 5.2 for the full sample,
survivors and exiters respectively. This is in line with the empirical
patterns reported in the literature (Klette et al., 2004; Aghion et al.,
2014). Secondly, mean R&D intensity is larger among exiters (0.30)
compared to survivors (0.16) or full sample (0.20). This is interest-
ing because it indicates that higher levels of R&D investment do not
necessarily ensure survival. Third, exiting ﬁrms: (i) are smaller with
mean employment of 69 compared to survivors (130) or full sam-
ple (113); (ii) have lower real turnover per employee with mean of
£201 thousand in 2010 prices compared to survivors (£214 thou-
sand) or full sample (£210 thousand); and (iii) grow slower than the
industry median growth (by −3%), whereas the growth differential
is positive for survivors (4%) and the full sample (2%).
Results from the log-normal estimation are in Table 2. Column
1 reports results from the baseline sample, which includes all ﬁrms
born after 1973, excluding top 1% of the R&D intensity distribu-
tion. Results in column 2 are for ﬁrms born in 2001 or after, with
a view to verify if coefﬁcient estimates are sensitive to left trunca-
tion. Columns 3 and 4 replicate the estimations in (1) and (2) by
taking account of frailty at the ﬁrm level.
The likelihood ratio test for frailty (Gutierrez, 2002) does not
reject the null hypothesis that the frailty coefﬁcient’s variance
() is zero. Hence, there is no systematic difference between the
estimates with and without frailty. Furthermore, levels of multi-
collinearity (VIF values) are below the commonly agreed upper
limit of 10.16 Finally, the sign, signiﬁcance and magnitude of the
estimates are largely consistent across estimations/samples, with
the exception of the Herﬁndahl index and its square. Given these
ﬁndings, our inference will be based on the baseline estimation
in Column 1 (Table 2), preferred on the basis of favourable log-
likelihood, AIC and BIC values.
However, we will qualify our inference in two ways. First, we
will compare the sign and signiﬁcance of each estimate in column
1 with the rest in Table 2. We  will infer that the ﬁnding in column
1 is upheld: (a) strongly if similarity across Table 2 is 75% or more;
(b) moderately if similarity is between 50%–74%; and (c) upheld
weakly if similarity is less than 50%. Then we  will take into account
the results from 10 sensitivity checks reported in Tables A2 and A3
in Appendix A. In Table A2, we  check if the results remain robust
to 6 different cut-off points for top R&D intensity. In Table A3, we
check if the results remain robust to 4 step-wise estimations. We
conclude that the estimated parameter in the baseline model is:
(a) strongly-robust, if it is consistent with all sensitivity checks
in Tables A2 and A3; (b) medium-robust, if it is consistent with
60% or more of the sensitivity checks; and (c) weakly-robust, if it
is consistent with less than 60% of the ﬁndings. To facilitate the
comparison, Table 3 below reports the signs and signiﬁcance of the
coefﬁcient estimates from model 1 in Table 2, together with their
consistency across Table 2 and their robustness to sensitivity checks
in Tables A2 and A3 in Appendix A.
Starting with the ﬁrst two  covariates of main interests (R&D
intensity and its square), we conclude that there is strong evidence
that the relationship between R&D intensity and survival time is
subject to decreasing scale effects and this ﬁnding is strongly-
robust to sensitivity checks. This is in line with the prediction of
16 The major contributors to mean VIF values are age and age-squared. When we
estimate the models without these covariates, the VIF value is around 4. Further-
more, the magnitude, signs and signiﬁcance of the estimates remain in line with
those in Table 2. These results are not reported here, but are available on request.
The correlation matrix for the covariates is presented in Table A4 in the Appendix
A.
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Fig. 1. Non-parametric survival functions. Survival rates by R&D intensity quartiles Survival rates by Herﬁndahl index quartiles.
the theoretical model we constructed and lends strong support for
Hypothesis 1.17
We  also ﬁnd that market concentration and R&D intensity might
be complements: a given level of R&D intensity is associated with
longer survival times if ﬁrms are located in more concentrated
industries. Both R&D intensity and market concentration enable
R&D-active ﬁrms in concentrated markets to increase the nor-
malised value of the knowledge production line and survive longer
than other ﬁrms with similar R&D intensity but lower market
power. However, the complementary is only weakly-robust to sen-
sitivity checks. An examination of Table A2 in Appendix A indicates
that this result is highly sensitive to the level of top R&D intensity
excluded from the analysis. Indeed, the effect disappears when the
cut-off point for top R&D intensity is at the 97th percentile or less.
Hence, we conclude that the support to Hypothesis 2 is sensitive to
skewness in the R&D intensity distribution. Despite this caveat, we
think that the ﬁnding is novel enough to warrant further research.
The negative relationship between survival time and industry-
level R&D intensity and lending premium is highly consistent across
estimations and highly robust to sensitivity checks.18 Our ﬁnd-
ings are also consistent with previous work (Audretsch, 1991;
Audretsch et al., 1995 on the effect of industry-level R&D inten-
sity; and Holmes et al., 2010 and Liu, 2004 on the effect of interest
rates). Hence, we conclude that there is strong support for Hypoth-
esis 3; and that the proposed model is versatile enough to explain
empirical patterns reported elsewhere.
The sign/signiﬁcance consistency of the Herﬁndahl index and
its square is low across Table 2; with a level of robustness to
sensitivity checks at 70%. We  interpret this as weak evidence
in support of a non-linear relationship between market concen-
17 As an anonymous reviewer has pointed out, the scale effect may  be speciﬁc
to  new innovation dynamics during the rise of the Internet. This argument can be
tested by comparing results from two comparable datasets before and after late
1990s. This is beyond the scope of this paper, but we strongly recommend testing
for  R&D scale effects with both recent and older data.
18 In the Appendix A, we  demonstrate that the negative effects of the discount rate
() and the rate of creative destruction (x) on survival depends on the following
condition: ( + x) > z where z is innovation intensity. This condition is satisﬁed in the
data, with median values as follows:  = 0.10; x = 0.03 and R&D intensity = 0.04.
tration and survival time. The ambiguity in the effect of market
concentration is in line with the existing literature. Whilst Mata
and Portugal (1994) and Wagner (1994) report insigniﬁcant or
ambiguous effects, McCloughan and Stone (1998), Baldwin and
Raﬁquzzaman (1995) and Helmers and Rogers (2010) ﬁnd sig-
niﬁcant positive effects. In addition, they resonate with an early
observation in Geroski (1991) who concludes that particular market
niches are more likely to be important to new entrants.
The positive and signiﬁcant coefﬁcients on age and size reﬂect
strong consistency within Table 2 and strong robustness to sen-
sitivity checks. They are also consistent with both theoretical and
empirical ﬁndings, which indicate that new entrants have shorter
survival time, but those that survive have longer survival times
(Erikson and Pakes, 1995; Klette et al., 2004; Aghion et al., 2014;
Ceﬁs et al., 2005; and Evans, 1987 among others).
However, controlling for non-linearities in the effects of age and
size has been an exception rather than the rule, e.g. Bhattacharjee
et al. (2009) and Ceﬁs and Marsili (2005). This issue has not been
emphasised in literature reviews (Geroski, 1995). Our ﬁndings
indicate absence of a non-linear relationship between age and
survival. This is in contrast to ‘liability of adolescence’ or ‘hon-
eymoon effect’ hypotheses that, respectively, posit U-shaped and
inverted-U shaped relationships between age and survival (Fichman
and Levinthal (1991). However, we ﬁnd strong support for an
inverted-U relationship between size and survival. This is in line
with evidence on size distribution and survival among Portuguese
ﬁrms (Cabral et al., 2003); and suggests that a large size beyond an
efﬁcient scale may  be a hazard factor in ﬁrm dynamics.
We report that the relationship between the number of plants
(local units) and ﬁrm survival is insigniﬁcant in the preferred model
(1). However, this ﬁnding is not supported by ﬁndings in the rest of
Table 2 and in sensitivity checks in Tables A3 and A4 in Appendix
A. The positive relationship is in line with Audretsch (1995), who
report that multi-plant ﬁrms have lower hazard rates because they
can diversify risks and/or restructure in the face of adverse shocks.
Hence, we conclude that our ﬁnding from the preferred model
should be treated with caution.
We also report that labour productivity (deﬂated turnover per
employee) and ﬁrm growth relative to 3-digit industry median
growth have positive effects on survival time. These ﬁndings are
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Table  2
R&D intensity, market concentration and ﬁrm survival.
Dep. variable: time to exit (1#) (2) (3) (4)
Covariates of main interest
Log (Total RD intensity + 1) 0.326*** 0.292*** 0.368*** 0.298***
(0.0591) (0.0773) (0.0633) (0.0774)
Log2 (Total R&D intensity + 1) −0.166*** −0.176*** −0.185*** −0.177***
(0.0301) (0.0396) (0.0348) (0.0397)
Log  (Total R&D intensity + 1)*HI 0.411** 0.959*** 0.377* 0.918***
(0.168) (0.235) (0.179) (0.234)
Herﬁndahl index (HI) −0.540*** 0.273 −0.195 −0.0474
(0.144) (0.189) (0.137) (0.183)
Herﬁndahl index2 0.762*** −0.490* 0.338 −0.248
(0.218) (0.263) (0.223) (0.267)
Median R&D int. in industry −0.317*** −0.813*** −0.405*** −0.708***
(0.0784) (0.0987) (0.0826) (0.100)
Lending premium −1.654*** 1.471*** −1.738*** 1.447***
(0.0479) (0.0877) (0.0474) (0.0882)
Other  ﬁrm-level covariates
Firm growth relative to 0.0319*** 0.0293*** 0.0331*** 0.0308***
industry growth (0.00494) (0.00640) (0.00501) (0.00645)
Fast  growth over 3 years −1.074*** −0.703*** −1.102*** −0.716***
before exit (0.0379) (0.0389) (0.0386) (0.0393)
Log  (Age) 0.537*** 2.669*** 0.528*** 2.662***
(0.0561) (0.0902) (0.0568) (0.0928)
Log2 (Age) −0.0175 −0.502*** −0.0172 −0.500***
(0.0136) (0.0248) (0.0138) (0.0257)
Log  (Employment) 0.232*** 0.217*** 0.232*** 0.209***
(0.0163) (0.0251) (0.0157) (0.0247)
Log2 (Employment) −0.0251*** −0.0290*** −0.0255*** −0.0283***
(0.00235) (0.00455) (0.00230) (0.00447)
Log  (Live local units + 1) 0.0263 0.0879*** 0.0418** 0.0978***
(0.0185) (0.0283) (0.0184) (0.0287)
Log  (Def. turnover/employee) 0.0988*** 0.0720*** 0.100*** 0.0696***
(0.00806) (0.0107) (0.00778) (0.0107)
Firm  engages in civil R&D only 0.0548*** 0.101*** 0.0347*** 0.0867***
(0.00999) (0.0153) (0.0105) (0.0156)
Firm  is UK-owned 0.0755*** 0.0304 0.0702*** 0.0153
(0.0213) (0.0450) (0.0215) (0.0456)
Other  industry-level covariates
Pavitt technology class 1 0.0312 −0.118 0.0617** 0.110***
(0.0947) (0.143) (0.0245) (0.0320)
Pavitt  technology class 2 0.176*** 0.138* 0.0932*** 0.0695**
(0.0615) (0.0766) (0.0232) (0.0290)
Pavitt  technology class 3 0.0583 0.170* −0.00126 0.00630
(0.0594) (0.0887) (0.0304) (0.0486)
Pavitt  technology class 5 0.105 0.0666 0.0627* 0.0632*
(0.0706) (0.0782) (0.0321) (0.0383)
Other  macro-level covariates
Average eff. exchange rate −0.0553*** −0.0300*** −0.0556*** −0.0297***
(0.000695) (0.00105) (0.000686) (0.00105)
Crisis  dummy −0.135*** −0.597*** −0.132*** −0.591***
(0.00918) (0.0297) (0.00934) (0.0300)
Constant 4.843*** 0.705*** 4.849*** 0.408**
(0.252) (0.265) (0.104) (0.163)
Observations 168626 38949 168306 38949
Number of subjects (ﬁrms) 36821 12416 36798 12416
Log  likelihood −28684.7 −9243.8 −28970.7 −9399.4
AIC  57585.4 18697.6 57991.4 18850.7
BIC  58669.2 19597.5 58242.3 19073.6
  0.685*** 0.578*** 0.692*** 0.583***
  1.430E-08 7.79e-09
VIF# 7.46 6.19 7.46 6.19
2-digit industry dummies Yes Yes No No
Robust standard errors in parentheses. *p < 0.10, **p < 0.05, ***p < 0.01. Top 1% of R&D intensity is excluded from all estimations. 1# = All ﬁrms born in 1974 or after (preferred
model); 2 = Firms born in 2001 and after; 3 = Model (1) with frailty; 4 = Model (2) with frailty.
strongly consistent across estimations and sensitivity checks. The
positive relationship between survival and ﬁrm growth is in line
with empirical ﬁndings reported in previous studies (Doms et al.,
1995; Mata et al., 1995; Agarwal, 1997; Ceﬁs et al., 2005). The added
value of our ﬁnding is that the positive effect of growth on survival
holds even after correcting for industry ﬁxed effects. The positive
relationship between labour productivity and survival is also in line
with Olley and Pakes (1992), who demonstrate that low productiv-
ity is a major cause of exit. It is also in line with the ‘shadow of
death’ argument in Griliches and Regev (1995), who report from
Israeli data that exiting ﬁrms are signiﬁcantly less productive.19
However, our ﬁndings also indicate that aggressive growth
strategies may  reduce survival time (we thank an anonymous
19 This is indeed what we observe in the UK data too−with lower real turnover per
employee among exiters compared to survivors and the full sample (see, summary
statistics in Table A1 in the Appendix A).
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Table 3
Consistency of parameter estimates: Baseline model versus different estimations and sensitivity checks.
Sign and signiﬁcance in
baseline model in Table
2
% of similarity in
Table 2
Consistency with 10
sensitivity checks (in
Tables A3 and A4)
Robustness to
sensitivity checks
Log (Total RD int. + 1) +*** 100% 100% Strongly-robust
Log2 (Total R&D int. + 1) −*** 100% 100% Strongly-robust
Log  (Total R&D intensity + 1)*HI +*** 100% 40% Weakly-robust
Herﬁndahl index (HI) −*** 25% 70% Medium-robust
Herﬁndahl index2 +*** 50% 70% Medium-robust
Median R&D intensity in industry −*** 100% 80% Strongly-Robust
Lending premium −*** 100% 100% Strongly-robust
Firm  growth relative to industry growth +*** 100% 100% Strongly-robust
Fast  growth over last 3 years before exit −*** 100% 100% Strongly-robust
Log  (Age) +*** 100% 80% Strongly-robust
Log2 (Age) Insigniﬁcant 50% 80% Strongly-robust
Log  (Employment) +*** 100% 100% Strongly-robust
Log2 (Employment) −*** 100% 100% Strongly-robust
Log  (Live local units + 1) Insigniﬁcant 25% 10% Weakly-robust
Log  (Def. turnover/employee) +*** 100% 100% Strongly-robust
Firm  engages in civil R&D only +*** 100% 80% Strongly-Robust
Firm  is UK-owned +*** 50% 90% Strongly-Robust
Pavitt technology class1 Insigniﬁcant 50% 80% Strongly-Robust
Pavitt technology class2 +*** 100% 100% Strongly-robust
Pavitt technology class3 Insigniﬁcant 25% 80% Strongly-robust
Pavitt technology class5 Insigniﬁcant 25% 80% Strongly-robust
Average eff. exchange rate −*** 100% 100% Strongly-robust
Crisis  dummy −*** 100% 100% Strongly-robust
Comparing the ﬁnding from baseline model in column 1 of Table 2 with the rest of Table 2 and sensitivity checks in Tables A3 and A4 in Appendix A. *p < 0.10, **p < 0.05,
***p < 0.01.
Table 4
Firms and ﬁrm characteristics after the turning points.
(1) (2) (3) (4) (5) (6) (7)
Linear R&D coefﬁcient 0.439 0.52 0.721 0.763 5.854 0.38 0.326
Quadratic R&D coefﬁcient −0.288 −0.388 −0.675 −0.768 −33.79 −0.228 −0.166
R&D*Herﬁndahl index# 0.409 0 0 0 0 0 0.411
Median Herf. index in sample 0.06 0.06 0.06 0.06 0.06 0.06 0.06
Turning point [log (RD +1)] 0.80 0.67 0.53 0.50 0.09 0.83 1.06
Turning point (R&D intensity) 1.24 0.95 0.71 0.64 0.09 1.30 1.88
Total  ﬁrms above turning point 3441 4260 5323 5731 18,297 337 2485
Total  ﬁrms in sample 36,699 36,553 36,244 36,201 32,014 11,644 36,821
%  of ﬁrms above turning point 9.38 11.65 14.69 15.83 57.15 2.89 6.75
Mean  employment above turning point 23 27 30 31 51 97 22
Mean  employment in sample 114 115 117 117 135 162 113
Mean  R&D int. above turning point 3.06 2.58 2.12 1.98 0.57 3.32 3.16
Mean  R&D intensity in sample 0.16 0.13 0.11 0.10 0.04 0.07 0.20
Samples vary by cut-off points for top R&D intensity percentiles and sector composition. (1): top 2% cut-off, all sectors; (2): top 3% cut-off, all sectors; (3): top 5% cut-off,
all  sectors; (4): cut-off at R&D intensity of 1 or more, all sectors; (5): top 25% cut-off, all sectors; (6): top 1% cut-off, manufacturing ﬁrms only; (7): top 1% cut-off, baseline
sample. #: a value of 0 indicates that the coefﬁcient estimate is insigniﬁcant.
reviewer for pointing to this possibility). Speciﬁcally, we ﬁnd that
ﬁrms that grow faster than the industry median for three consec-
utive years before exit have shorter survival times. This ﬁnding
is compatible with case-study evidence indicating that aggressive
growth strategies may  be detrimental to ﬁrm performance in the
absence of appropriate growth management strategies. The lat-
ter should be in place to address fast-growth challenges such as
training, customer support, increased management delegation, and
investment in enhanced organisational structures (Greening et al.,
1996; Oliva et al., 2003). The fast-growth ﬁrms are similar to oth-
ers in terms of R&D intensity and productivity, but they are much
smaller − with mean employment of 16 against 114 in the rest
of companies.20 Hence, we cautiously suggest that the negative
relationship between fast growth and survival in our data may  be
reﬂecting overstrained ambitions for increased market shares.
20 Fast-growing ﬁrms are also smaller when size is measured with deﬂated
turnover, with a mean of £5.2 m against £24.2 m for other ﬁrms.
Two other ﬁrm characteristics that may  be speciﬁc to UK  ﬁrms
are found to have positive effects on survival: UK ownership (with
medium support) and engagement in civil R&D only (with strong
evidential support). Both coefﬁcient estimates are strongly-robust
to sensitivity checks. Longer survival among UK-owned ﬁrms is in
line with Sharapov et al. (2011). This may  be due to better local
knowledge of UK-owned ﬁrms and/or aggressive relocation strate-
gies of the foreign-owned ﬁrms, who relocate to other countries
in the face of adverse market conditions in the UK. Furthermore,
longer survival among ﬁrms engaged in civil R&D may  be due to
absolute and relative decline in UK defence expenditures. Since late
1980s, defence-related R&D expenditures in the UK fell from £5 bn
in 1989 to £2 bn in 2012 in constant prices (ONS, 2014). In addi-
tion, the difference between civil and defence R&D expenditures
has widened in favour of the former, from £10 bn in to £22 bn over
the same period (ONS, 2014). We  conjecture that some of the ﬁrms
engaged in defence-related R&D may  have exited due to reduced
government subsidies for defence-related R&D
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We  also ﬁnd that ﬁrms specialised in the supply of technol-
ogy (Firms in Pavitt class 2 that includes mechanical engineering,
manufacturing of electrical equipment, renting of machinery, etc.)
have longer survival times relative to other technology classes. This
ﬁnding is in line with Agarwal and Audretsch (2001) and Ceﬁs
and Marsili (2005) and it indicates that the nature of the technol-
ogy in the industry matters. We  conjecture that Pavitt2 ﬁrms may
be enjoying speciﬁc market niches, but this issue requires further
investigation.
Finally, our ﬁndings indicate that the macroeconomic environ-
ment has a signiﬁcant effect on ﬁrm survival. In addition to the
negative effect of the lending premium discussed above, we ﬁnd
that the onset of a ﬁnancial crisis and currency appreciation tend
to reduce survival time. These ﬁndings are supported by strong
evidence and remain highly consistent across various sensitivity
checks. They are also in line with those reported in few studies
(Bhattacharjee et al., 2009; Goudie et al., 1991). The evidence we
report here can go some way towards bridging the evidence gap,
which led earlier reviewers to conclude that the empirical work
controlling for macroeconomic conditions leaves the “impression
that . . . hazard rates are rather insensitive to the observed variation
in the macro environment” (Caves, 1998).
4.2. Turning points for R&D intensity
Three issues arise in the context of quadratic speciﬁcations:
(i) whether the linear and quadratic terms are jointly signiﬁcant;
(ii) whether the turning point occurs within the sample range
for R&D intensity; and (iii) the number of ﬁrms above the turn-
ing point and their characteristics. We  have addressed issue (i) by
conducting likelihood ratio tests of joint signiﬁcance for the lin-
ear and non-linear terms, all of which indicate joint signiﬁcance
in all reported estimates. To address issues (ii) and (iii), we  calcu-
lated the levels of R&D intensity that constitute the turning point for
the inverted-U curve,21 and some descriptive statistics that provide
information about the ﬁrms with R&D intensity above the turning
point (Table 4). Columns 1–6 report evidence related to the same
samples in Table A3 in Appendix A. Column 7 reports evidence
related to the preferred model (column 1) in Table 2 above.
The percentage of ﬁrms with R&D intensity above the turning
point is not trivial − it ranges between 2.9% and 57%. Hence, the
scale effect in the relationship between R&D intensity and ﬁrm sur-
vival is not an aberration caused by an arbitrary cut-off point for
the top R&D intensity. As expected, the mean R&D intensity above
the turning point is always much larger than the mean R&D inten-
sity in the sample (cf. last two rows of Table 4). We  observe that
ﬁrms above the turning point are smaller in terms of employment.
Given that we already control for size (ﬁrm employment) in the
estimations, we conclude that the downward-sloping relationship
between R&D intensity and survival time after the turning points
is driven by diminishing scale effects rather than size.
5. Conclusions
In this paper, we set out with the observation that empirical
ﬁndings on the relationship between input or output measures of
innovation and ﬁrm survival are varied and often conﬂicting. We
also observed that this is in contrast to largely convergent ﬁndings
on the relationship between survival and a wide range of ﬁrm-,
21 The turning points are calculated as follows. Let ∂E[t]
∂RDint
= ˇ1 + 2ˇ2RD int +
ˇ3HI = 0, where RD int is total R&D intensity and HI is median Herﬁndahl index
in  the sample. Then the turning point for R&D intensity is given by: RD int =(
ˇ1 + ˇ3HI
)
/
(
−2ˇ2
)
.
industry- or macro-level factors. Hence, we argued that the varia-
tion in the evidence base may  be due to lack of control in existing
models for scale effects in the relationship between R&D intensity
and survival and possible complementarity/substitution effects in
the relationship between R&D intensity and market concentration.
To test these arguments, we proposed a theoretical model
informed by Schumpeterian perspectives on competition, inno-
vation and growth. The proposed model predicts an inverted-U
pattern in the relationship between R&D intensity and ﬁrm survival.
It also implies that R&D intensity and market concentration are
complements; and creative destruction (proxied by industry-level
R&D intensity) and the discount rate (proxied by business lending
premium) are negatively associated with survival time.
We have tested these predictions using UK data for 37,930 ﬁrms
from 1998 to 2012. The diminishing scale effect is strongly consis-
tent across different samples and estimations with and without
frailty. We have also found medium evidential support for the
prediction that innovation and market concentration are comple-
ments. However, this ﬁnding is only weakly-robust to skewness in
the R&D intensity. Finally, we  report that the model’s predictions
concerning the negative effects of creative destruction and the dis-
count rate are supported by UK evidence. These ﬁndings contribute
to existing knowledge by highlighting the importance of controlling
for: (i) scale effects in R&D intensity; (ii) complementarity between
the latter and market concentration; and (iii) the roles of creative
destruction and discount rate. The evidence with respect to direct
effects of market concentration remains inconclusive.
Secondly, we  ﬁnd that ﬁrm growth above the industry median
over a sustained period before exit is associated with shorter sur-
vival time. We  interpret this as a reﬂection of overstrained growth
strategies, whereby smaller ﬁrms that focus on growth as a means
of enhancing market share face a higher risk of exit, perhaps due
to a gap between their growth ambitions and growth management
capacity.
Thirdly, our ﬁndings concerning the effects of a wide range of
ﬁrm-, industry- and macro-level covariates such as age, size, and
productivity, ﬁrm growth relative to the industry, technology class,
crisis years, and international competitiveness are all consistent
across estimations and in line with the existing literature.
One implication of our ﬁndings for future research is that it is
necessary to control for scale effects in the relationship between
R&D intensity and survival. This can be done with new datasets
and as replications of the existing studies, which tend to adopt
a linear speciﬁcation for the relationship between R&D intensity
and survival. Controlling for scale effects is advisable because it
allows researchers to establish whether the relationship between
R&D intensity and ﬁrm survival is monotonic or subject to increas-
ing or decreasing scale effects; and whether the scale effects vary
between industries or over time.
Another implication is that controlling for complementarity or
substitution between R&D intensity and market power is justiﬁed
on both theoretical and empirical grounds. Although our ﬁndings
lend only moderate support for complementarity between R&D
intensity and market concentration, we are of the view that control-
ling for complementarity/substitution between R&D intensity and
a better measure of market power is a fruitful avenue for future
research. We  suggest that market power indices based on proﬁt
margins, corrected for efﬁciency as suggested by Boone (2008a,b),
can be used by researchers drawing on publicly available ﬁnancial
data for listed and unlisted ﬁrms. This line of research can shed
additional light on whether the survival effects of R&D investment
are mediated through market power (escape-competition effect)
or increased efﬁciency (competition effect).
In terms of policy and practice, our ﬁndings indicate that there
may  be an ‘optimal’ level of R&D investment for maximising sur-
vival time, but the optimal level is likely to differ depending on the
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Fig. A1. Kernel density plot for R&D intensity in the estimation sample.
Note: The level of R&D intensity skewness in the sample is very high (+6.70). The
number of observations with zero R&D intensity is 2459 (1.33% of the total). The
number of observations with R&D intensity greater than 1 is 9769 (or 5.3% of the
total). Mean value of R&D intensity is 0.20.
level of creative destruction in the industry, the level of product-
market competition, and the extent of skewness in the distribution
of R&D intensity. Such variations, however, are part and parcel of
the ‘active learning’ process that shapes the decisions of both ﬁrm
managers and policy-makers aiming to maximise the returns on
R&D investment.
Appendix A. A survival model with R&D scale effects.
Drawing on Aghion et al. (2014), we begin with a ﬁrm that com-
bines a number of scientists (Si) with a stock of knowledge (k) and
generates a Poisson count of innovation ﬂows (Zi) in accordance
with a Cobb-Douglas production function with constant returns to
scale Eq. (A1)(. )
Zi =
(
Si

) 1

k
1− 1
i
(A1)
Here,  is scaling factor, 1/  < 1 and denotes the elasticity of
innovation ﬂows with respect to scientists, and k is the number of
knowledge production lines (knowledge stock). The latter increases
to k + 1 when R&D investment is successful; but also decreases to k-
kx when creative destruction occurs at the rate of x. From Eq. (A1),
the total and average cost functions are:
C (zi, k) = wkzi (Total cos tofknowledgeproduction) (A2.1)
C (zi) = wzi (Average cost ofknowlegdeproduction per innovation line)
The total and average costs increase with wage rate (w) and
innovation intensity (zi), deﬁned as zi = Zi/k.  Finally, the average
normalized value of the knowledge production line is determined
endogenously by ﬁrm and industry characteristics in accordance
with Eq. (A3):
v =  − wz

i
 + x − zi
= A
 + x − zi
(A3)
In Eq. (A3),  is gross proﬁt per innovation line, A is gross prof-
its adjusted for cost of innovation,  is discount rate, and x is the
rate of creative destruction in the industry.22 The ﬁrm chooses its
innovation intensity (zi) to maximise the average value per knowl-
edge production line (v). The latter increases with gross proﬁts, but
decreases with the discount rate () and with the rate of creative
destruction in the industry (x).23 The effect of innovation intensity
on normalised value is non-linear: v increases through the linear
term in the denominator (zi), but decreases with the non-linear
term in the numerator (z
i
).
Denoting ﬁrm output at time t with Yt and the knowledge pro-
duction lines with k, Aghion et al. (2014) derive the balanced-path
value Vt (k)of the ﬁrm as:
Vt (k) = kYtv (A4)
We utilize the model to evaluate the effect of R&D intensity on
ﬁrm survival. To do this, we depart from Aghion et al. (2014), where
the ﬁrm exits when it loses all of its knowledge production lines due
to creative destruction. Instead, we  hypothesize that the ﬁrm exits
when its market value is zero.
The use of ﬁrm value for modelling survival time requires that
the market prices the ﬁrm’s R&D investment correctly. Some stud-
ies report that returns on R&D-intensive stocks are not higher than
those of non-R&D-intensive ﬁrms (Chan et al., 1999). However, a
larger body of work reports that the effect of R&D intensity on the
ﬁrm’s stock-market value is positive and strong, even though the
coefﬁcients ﬂuctuate over time (Hall, 2006; Chauvin et al., 1993;
Ehie and Olibe, 2010). Given these ﬁndings, we assume that the
ﬁrm’s market value can be taken as approximately equal to ﬁrm
value in Eq. (A4).
Assuming that the ﬁrm’s market value follows a Wiener process
until liquidation (McDonald and Siegel, 1985), we can write the
log-normally distributed value of the ﬁrm as a function of time as
follows:
Vt (k) = kYtv ∼= V0e
[(
− 22
)
t+√tN(0,1)
]
(A5)
Here, V0 is the ﬁrm’s initial value,  and  are drift and volatility
parameters respectively, t is time to exit (liquidation), and N(0, 1)
is the standard normal distribution with mean 0 and a variance of
1. Taking logarithms across and noting that the expected value of
the standard-normal variable is zero, we obtain Eq. (A6):
E [Vt (k)] = E [ln (k) + lnYt + lnv] ∼= E [lnVo] +
(
 − 
2
2
)
E [t] (A6)
Given that the initial (V0) is constant and that the expected val-
ues of k, Yt and v are equal to their equilibrium values; we can
write:
ln (k) + lnYt + lnv ∼= lnVo +
(
 − 
2
2
)
E [t] (A7)
From Eq. (A7), we  can derive the expected value of survival time
as:
E [t] ∼= 2
2 − 2 [ln (k) + lnYt − lnVo + lnv] (A8)
Replacing v with its equivalent in (3), we obtain:
E [t] ∼= 2
2 − 2
[
ln (k) + ln
(
Yt
V0
)
+ ln − wz

i
 + x − zi
]
(A9)
22 Optimising behaviour requires that adjusted gross proﬁt is strictly positive − i.e.,
  − wzn
i
= A > 0. Otherwise, the ﬁrm is better off shutting down the knowledge
production line(s) with zero or negative value.
23 A higher discount rate reﬂects a higher opportunity cost for a given level of
innovation intensity (zi), and the rate of creative destruction in the industry renders
the ﬁrm’s technology obsolete.
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Table  A1
Summary statisticsa.
Full sample
Variable N Mean Min. Max. Skew.
R&D intensity (RD int) 185,094 0.20 * * 6.70
RD  int - squared 185,094 0.39 * * 11.94
R&D  int * HI 185,094 0.02 0 4.37 14.05
Herﬁndahl index (HI) 185,094 0.10 0.01 1 3.09
HI-squared 185,094 0.02 5.7E-5 1 7.66
Relative growth 172,477 0.02 −9.57 11.76 0.40
Fast  growth dummy 172477 0.01 0.00 1.00 13.54
Age  185,094 14.27 * * 0.47
Age  -squared 185,094 277.78 * * 1.43
Employment (Emp) 185,094 113.36 * * 68.55
Emp-  squared 185,094 128E+4 * * 118.55
Live  local units 185,094 1.92 * * 168.11
Productivity 184,893 210.26 * * 127.90
Civil  R&D only 185,094 0.42 * * 0.34
UK-owned 185,094 0.88 * * −2.37
Median R&D intensity in industry 172,477 0.08 0 2.87 2.07
Pavitt class 1 185,094 0.36 0 1 0.60
Pavitt class 2 185,094 0.22 0 1 1.38
Pavitt class 3 185,094 0.09 0 1 2.80
Pavitt class 4 185,094 0.27 0 1 1.03
Pavitt class 5 185,094 0.06 0 1 3.55
Effective exch. rate 185,094 92.47 79.99 103.67 −0.30
Crisis dummy 185,094 0.15 0 1 1.93
Lending premium 185,094 0.12 −0.034 0.383 0.67
Number of ﬁrms 37,930
Survivors
Variable N Mean Min. Max. Skew.
R&D intensity (RD int) 134,626 0.16 * * 7.68
RD  int - squared 134,626 0.29 * * 14.22
R&D  int * HI 134,626 0.02 0 4.37 15.09
Herﬁndahl index (HI) 134,626 0.10 0.01 1 3.07
HI-squared 134,626 0.02 5.7E-5 1 7.45
Relative growth 128,791 0.04 −7.33 11.76 0.84
Fast  growth dummy 128791 0.00 0.00 0.00 .
Age  134,626 15.65 * * 0.33
Age  -squared 134,626 319.68 * * 1.23
Employment (Emp) 134,626 130.07 * * 61.51
Emp-  squared 134,626 166E+4 * * 103.73
Live  local units 134,626 2.19 * * 145.65
Productivity 134,544 213.78 * * 142.79
Civil  R&D only 134,626 0.43 * * 0.29
UK-owned 134,626 0.87 * * −2.24
Median R&D intensity in industry 128,791 0.07 0 2.87 2.40
Pavitt class 1 134,626 0.32 0 1 0.76
Pavitt class 2 134,626 0.22 0 1 1.32
Pavitt class 3 134,626 0.10 0 1 2.68
Pavitt class 4 134,626 0.29 0 1 0.93
Pavitt class 5 134,626 0.06 0 1 3.54
Effective exch. rate 134,626 90.82 79.99 103.67 0.05
Crisis dummy 134,626 0.13 0 1 2.17
Lending premium 134,626 0.11 −0.034 0.38 0.74
Number of ﬁrms 24,412
Exiters
Variable N Mean Min. Max. Skew.
R&D intensity (RD int) 50,468 0.30 * * 5.19
RD  int - squared 50,468 0.68 * * 8.89
R&D  int*HI 50,468 0.03 0 3.57 11.99
Herﬁndahl index (HI) 50,468 0.09 0.01 1 3.15
HI-squared 50,468 0.02 5.7E − 5 1 8.29
Relative growth 43,686 −0.03 −9.57 9.11 −0.09
Fast  growth dummy 43686 0.02 0.00 1.00 6.65
Age  50,468 10.61 * * 0.82
Age  -squared 50,468 166.03 * * 2.15
Employment (Emp) 50,468 68.81 * * 95.65
Emp-  squared 50,468 26E + 04 * * 222.4
Live  local units 50,468 1.19 * * 33.78
Productivity 50,349 200.84 * * 85.75
Civil  R&D only 50,468 0.38 * * 0.49
UK-owned 50,468 0.91 * * −2.81
1486 M. Ugur et al. / Research Policy 45 (2016) 1474–1492
Table A1 (Continued)
Exiters
Variable N Mean Min. Max. Skew.
Median R&D intensity in industry 43,686 0.11 0 2.16 1.42
Pavitt  class 1 50,468 0.45 0 1 0.21
Pavitt  class 2 50,468 0.19 0 1 1.57
Pavitt  class 3 50,468 0.08 0 1 3.17
Pavitt  class 4 50,468 0.22 0 1 1.36
Pavitt  class 5 50,468 0.06 0 1 3.57
Effective exch. rate 50,468 96.86 79.99 103.67 −1.53
Crisis  dummy 50,468 0.21 0 1 1.45
Lending premium 50,468 0.14 −0.034 0.38 0.46
Number of ﬁrms 13,518
a Minimum and maximum values are suppressed to comply with non-disclosure requirements of the data hosts, UK Data Service. Firms born after 1973, excluding top 1%
of  R&D intensity distribution. All covariates are as described in Table 1. Pavitt technology classes are as described in note 5.
Eq. (A9) informs the three hypotheses spelled out in the main
text. However, the validity of those hypotheses hinges on three
assumptions.
First, the elasticity of innovation ﬂow with respect to scientists
is positive but less than 1, i.e.:
0 < 1⁄ < 1 (A10)
This assumption implies that innovation ﬂows are produced not
by scientists (Si) only, but by combining the scientist input with an
existing stock of knowledge (k)We  argue that this assumption holds
because otherwise the elasticity of innovation ﬂow with respect
to knowledge capital (k) is zero or negative (i.e., 1 − 1⁄ ≤ 0). This
scenario, however, is unrealistic given the extensive evidence that
knowledge capital measured as R&D capital stock has a positive
effect on productivity−see Griliches (1979) on theoretical and mea-
surement issues, and Hall et al. (2010) and Ugur et al. (2015) for
reviews.
Secondly, proﬁts adjusted for innovation cost must be positive
− i.e.:
 − wz
i
= A > 0 (A11)
We argue that this assumption also holds because otherwise the
ﬁrm is better-off shutting down the knowledge production lines
that generates loss or no proﬁts.
Finally, the volatility parameter () in the Wiener process is
small relative to the drift parameter (). Speciﬁcally:
 <
√
2 (A12)
This assumption is compatible with existing evidence, which
indicates that the volatility parameter is usually around one-tenth
of the drift parameter in a large number of stock markets including
the UK (Casas et al., 2008).
Provided that these assumptions are satisﬁed, it can be estab-
lished that the turning point for the survival time as a function
of innovation intensity is a local maximum, which indicates a
diminishing scale effect in the relationship between survival and
innovation intensity.
To demonstrate this, ﬁrst take the ﬁrst-order partial derivative
with respect to innovation intensity (zi) and set equal to zero, to
obtain:
∂E[t]
∂zi
∼= 2
2 − 2
 + x − zi
 − wz
i
[
−wz−1
i
( + x − zi) +
(
 − wz
i
)]
( + x − zi)2
= 2
2 − 2
[
( + x − zi)
[
−wz−1
i
( + x − zi) +
(
 − wz
i
)](
 − wz
i
)
( + x − zi)2
]
= 2(
2 − 2
)
[
−wz−1
i
( + x − zi)2 +
(
 − wz
i
)
( + x − zi)(
 − wz
i
)
( + x − zi)2
]
= 2
2 − 2
[
1
 + x − zi
−
wz−1
i
 − wz
i
]
= 0 (A13)
Recalling that  <
√
2, the ﬁrst term is positive − i.e., 2
2−2 >
0. Also, recalling that adjusted proﬁts are positive (i.e., wz−1
i
>
0), the ﬁrst-order condition for observing an extremum in survival
time is given in Eq. (A14):
1
 + x − zi
− wz
−1
i
 − wz
i
= 0 or 1
 + x − zi
= wz
−1
i
 − wz
i
(A14)
Multiplying both sides with  − wz
i
and recalling that v =
−wz
i
+x−zi , we  obtain:
wz−1
i
=  − wz

i
 + x − zi
= v (A15)
Stated explicitly, Eq. (A15) indicates that the extremum for sur-
vival time as a function of innovation intensity occurs when the
marginal cost innovation intensity (left-hand side) is equal to the
normalised value of the knowledge production line (right-hand
side). This is compatible with optimising ﬁrm behaviour.
Whether the turning point is a local maximum depends on the
second-order condition, which can be stated as follows.
∂2E [t]
∂zi2
∼= 2(
2 − 2
) [ 1
( + x − zi)2
−
 ( − 1) wz−2i
(
 − wzi
)
+ wz−1i wz
−1
i(
 − wzi
)2
]
< 0
. (A16)
Noting that  − wz
i
= A from Eq. (A3) and wz−1i = v from
the ﬁrst-order condition in Eq. (A15), we obtain:
∂2E [t]
∂zi2
∼= 2(
2 − 2
) [ 1
( + x − zi)2
−  ( − 1) v
−2A + v2
2A
]
< 0
(A17)
Recalling that  <
√
2 and A > 0 from Eqs. (A12) and (A11),
the second-order condition for a local maximum boils down to:
∂2E [t]
∂zi2
∼= 1
( + x − zi)2
−  ( − 1) v
−2A + v2
2A
< 0. (A18.1)
Multiplying both sides of the inequality with 2A, we  obtain:
2A
( + x − zi)2
−
[
 ( − 1) v−2A + v2
]
< 0 (A18.2)
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Table  A2
Sensitivity checks for different cut-off points of R&D intensity.
Dep. variable: time to exit (1) (2) (3) (4) (5) (6)
Log(Total RD intensity + 1) 0.439*** 0.520*** 0.721*** 0.763*** 5.854*** 0.380**
(0.0762) (0.0988) (0.138) (0.143) (0.667) (0.162)
Log2 (Total R&D intensity + 1) −0.288*** −0.388*** −0.675*** −0.768*** −33.79*** −0.228**
(0.0529) (0.0917) (0.188) (0.204) (4.597) (0.0896)
Log(Total R&D intensity + 1)*HI 0.409* 0.326 0.00604 −0.0451 −1.239 0.400
(0.213) (0.278) (0.379) (0.393) (1.545) (0.547)
Herﬁndahl index (HI) −0.527*** −0.519*** −0.501*** −0.498*** 0.0181 −0.487
(0.146) (0.149) (0.152) (0.152) (0.172) (0.334)
Herﬁndahl index2 0.748*** 0.741*** 0.731*** 0.732*** 0.0705 0.883
(0.219) (0.221) (0.223) (0.224) (0.265) (0.701)
Median R&D int. in industry −0.342*** −0.387*** −0.481*** −0.482*** −0.611*** 1.498***
(0.0799) (0.0824) (0.0882) (0.0897) (0.136) (0.491)
Lending premium −1.662*** −1.659*** −1.664*** −1.663*** −1.805*** −2.476***
(0.0483) (0.0489) (0.0500) (0.0501) (0.0621) (0.0906)
Firm  growth relative to 0.0331*** 0.0355*** 0.0416*** 0.0428*** 0.0570*** 0.0535***
Industry growth (0.00511) (0.00531) (0.00561) (0.00566) (0.00776) (0.0110)
Fast  growth over 3 years −1.081*** −1.103*** −1.128*** −1.128*** −1.412*** −1.420***
Before exit (0.0383) (0.0390) (0.0400) (0.0401) (0.0554) (0.113)
Log  (Age) 0.534*** 0.531*** 0.532*** 0.532*** 0.450*** 0.337***
(0.0565) (0.0571) (0.0581) (0.0582) (0.0738) (0.129)
Log2 (Age) −0.0162 −0.0149 −0.0137 −0.0133 0.00642 0.0205
(0.0137) (0.0138) (0.0140) (0.0140) (0.0172) (0.0283)
Log  (Employment) 0.228*** 0.227*** 0.224*** 0.222*** 0.202*** 0.178***
(0.0164) (0.0166) (0.0168) (0.0168) (0.0189) (0.0307)
Log2 (Employment) −0.0246*** −0.0244*** −0.0240*** −0.0239*** −0.0208*** −0.0166***
(0.00236) (0.00238) (0.00240) (0.00240) (0.00268) (0.00385)
Log  (Live local units + 1) 0.0262 0.0270 0.0264 0.0260 0.0364* 0.00317
(0.0186) (0.0188) (0.0190) (0.0190) (0.0216) (0.0332)
Log  (Def. turnover/employee) 0.0997*** 0.0999*** 0.100*** 0.100*** 0.120*** 0.124***
(0.00821) (0.00838) (0.00864) (0.00867) (0.0100) (0.0169)
Firm  engages in civil R&D only 0.0551*** 0.0549*** 0.0560*** 0.0562*** 0.0492*** −0.00788
(0.0101) (0.0102) (0.0104) (0.0104) (0.0126) (0.0169)
Firm  is UK-owned 0.0746*** 0.0732*** 0.0728*** 0.0733*** 0.0563** 0.00985
(0.0214) (0.0215) (0.0217) (0.0217) (0.0244) (0.0296)
Pavitt  technology class 1 0.0301 0.0282 0.0313 0.0308 0.0171 −0.0683
(0.0952) (0.0957) (0.0967) (0.0968) (0.0301) (0.123)
Pavitt  technology class 2 0.175*** 0.172*** 0.173*** 0.173*** 0.0613** 0.159*
(0.0617) (0.0621) (0.0626) (0.0627) (0.0264) (0.0820)
Pavitt  technology class 3 0.0564 0.0536 0.0597 0.0595 −0.0232 0.0234
(0.0596) (0.0600) (0.0606) (0.0606) (0.0328) (0.0663)
Pavitt  technology class 5 0.104 0.105 0.101 0.102 0.0515 0.210
(0.0708) (0.0712) (0.0717) (0.0719) (0.0363) (0.223)
Average eff. exchange rate −0.0554*** −0.0557*** −0.0559*** −0.0559*** −0.0607*** −0.0656***
(0.000701) (0.000709) (0.000722) (0.000724) (0.000868) (0.00147)
Crisis  dummy −0.134*** −0.134*** −0.138*** −0.138*** −0.139*** −0.0430***
(0.00925) (0.00938) (0.00962) (0.00965) (0.0124) (0.0145)
Constant 4.850*** 4.873*** 4.903*** 4.898*** 5.237*** 6.015***
(0.253) (0.253) (0.261) (0.261) (0.128) (0.237)
Observations 167279 165733 162542 162140 130482 61296
Number of subjects (ﬁrms) 36699 36553 36244 36201 32014 11644
Log  likelihood −28489.2 −28232.3 −27624.6 −27550.2 −21296.2 −10259.6
AIC  57194.3 56680.6 55465.2 55316.4 42642.3 20615.2
BIC  58277.3 57762.5 56545.1 56396.0 42886.8 21048.3
VIF  7.52 7.62 7.73 7.73 7.96 9.91
  0.687*** 0.689*** 0.691*** 0.691*** 0.724*** 0.698***
2-digit industry dummies Yes Yes Yes Yes No Yes
Robust standard errors in parentheses. *p < 0.10, **p < 0.05, ***p < 0.01. Models 1–6 are based on full sample of ﬁrms born in 1974 and after, excluding the following R&D
intensities: (1) = top 2% cut-off; (2) = top 3% cut-off; (3) = top 5% cut-off; (4) = cut-off at R&D intensity at 1 or more; (5) top 25% cut-off; (6) = manufacturing ﬁrms born in 1974
or  after, excluding top 1% of R&D intensity distribution.
Noting that
2
A
(+x−zi)2
= v2, the second-order condition boils
down to:
 ( − 1) v−2A > 0. (A18.3)
Noting that 1/<1,  and hence  > 1;  ( − 1) > 0. Also, A > 0
and v−2 is a positive fraction. Hence, the second-order condition for
a local maximum is satisﬁed; and the relationship between inno-
vation intensity and survival time follows an inverted-U pattern.24
This result informs Hypothesis 1 of the paper.
The model also informs Hypothesis 2 of the paper, which indi-
cates that gross proﬁts and R&D intensity have complementary
24 Note that the model can yield other results if the restrictions on elasticity coefﬁ-
cients and adjusted proﬁts are relaxed. If 1/ > 0 (i.e., if the elasticity of knowledge
capital is negative), the model yields a U-shaped relationship between innovation
and survival. The relationship is indeterminate if 1/ = 0 (i.e., if the elasticity of
knowledge capital is zero). On the other hand, the model yields a U-shaped rela-
tionship between innovation intensity and survival if A < 0 and the relationship is
indeterminate if A = 0. However, we rule out these outcomes for reasons indicated
above.
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Table A3
Robustness checks − stepwise estimations.
Dep. Var.: Time to exit (1) (2) (3) (4)
Log (R&D intensity + 1) 0.253*** 0.476*** 0.354*** 0.338***
(0.0796) (0.0838) (0.0591) (0.0593)
Log  (R&D intensity + 1) sq. −0.0979** −0.207*** −0.172*** −0.169***
(0.0381) (0.0416) (0.0301) (0.0302)
Log(Total R&D intensity + 1)*HI 1.282*** 1.352*** 0.271 0.371**
(0.250) (0.250) (0.165) (0.165)
Herﬁndahl index (HI) 0.890*** 0.995*** −0.193 −0.399***
(0.193) (0.193) (0.137) (0.141)
Herﬁndahl index2 −0.903*** −1.055*** 0.336 0.459**
(0.299) (0.299) (0.223) (0.226)
Firm  growth relative to median 0.0310*** 0.0371*** 0.0321*** 0.0325***
Industry growth (0.00713) (0.00721) (0.00497) (0.00496)
Fast  growth for 3 years −1.835*** −1.830*** −1.102*** −1.093***
before exit (0.0607) (0.0605) (0.0385) (0.0382)
Log  (Age) −1.389*** −1.369*** 0.529*** 0.530***
(0.0816) (0.0814) (0.0567) (0.0565)
Log2 (Age) 0.368*** 0.364*** −0.0177 −0.0170
(0.0204) (0.0203) (0.0137) (0.0137)
Log  (Employment) 0.312*** 0.305*** 0.233*** 0.227***
(0.0233) (0.0236) (0.0157) (0.0160)
Log2 (Employment) −0.0320*** −0.0310*** −0.0256*** −0.0246***
(0.00345) (0.00345) (0.00230) (0.00231)
Log  (Live local units + 1) −0.0464* −0.0540** 0.0414** 0.0355*
(0.0275) (0.0275) (0.0184) (0.0184)
Log  (Def. turnover/employee) 0.196*** 0.200*** 0.100*** 0.0985***
(0.0117) (0.0118) (0.00776) (0.00794)
Civil  R&D only −0.0822*** −0.0822*** 0.0349*** 0.0468***
(0.0150) (0.0151) (0.0105) (0.0103)
Firm  is UK-owned 0.131*** 0.125*** 0.0702*** 0.0732***
(0.0323) (0.0322) (0.0215) (0.0214)
Median R&D intensity in −0.288*** −0.397*** −0.299***
Industry (0.112) (0.0822) (0.0844)
Pavitt  technology class 1 −0.0313 0.0616** 0.134***
(0.0360) (0.0244) (0.0313)
Pavitt  technology class 2 0.131*** 0.0937*** 0.153***
(0.0350) (0.0231) (0.0304)
Pavitt  technology class 3 −0.0714 −0.000965 0.0407
(0.0458) (0.0304) (0.0345)
Pavitt  technology class 5 0.0593 0.0633** 0.110**
(0.0492) (0.0321) (0.0545)
Average eff. exchange rate −0.0555*** −0.0556***
(0.000684) (0.000684)
Crisis  dummy −0.131*** −0.126***
(0.00931) (0.00925)
Lending premium −1.738*** −1.734***
(0.0473) (0.0474)
Constant 0.512*** 0.483*** 4.842*** 4.992***
(0.105) (0.107) (0.104) (0.172)
Industry dummies None None None 1-digit
–
Sigma  0.952*** 0.948*** 0.692*** 0.689***
Observations 168843 168626 168626 168626
AIC  69353.4 69142.5 58095.6 57971.2
BIC  69524.0 69363.3 58346.5 58402.8
VIF  9.91 8.19 7.46 7.46
Number of subjects 36836 36821 36821 36821
Log  likelihood −34659.7 −34549.3 −29022.8 −28942.6
Robust standard errors in parentheses. *p < 0.10, **p < 0.05, ***p < 0.01. All ﬁrms born in 1974 or after, excluding top 1% of R&D intensity. 1: with ﬁrm covariates only; 2: Model
(1)  + industry covariates; 3: Model (2) + Macro covariates; 4: Model (3) + 1-digit industry dummies.
effects on survival. To demonstrate that this is the case, we take
the second derivative of Eq. (A13) with respect to gross proﬁts ().
∂2E [t]
∂zi∂
= 2
2 − 2
[
1(
 − wz
i
)2
]
> 0 (A19)
The second derivative is positive since the denominator is a
squared term and 2/2 − 2 > 0, as indicated above. Hence, hold-
ing the level of innovation intensity constant, an increase in gross
proﬁts is associated with an increase in survival time.
We can also show that the model informs Hypothesis 3, which
posits that higher discount rates and rates of creative destruction
in the industry reduce the normalised value of the knowledge pro-
duction line and hence survival time. To demonstrate the negative
relationship with survival time, we  take the derivatives of Eq. (A9)
with respect the discount rate () and the rate of creative destruc-
tion (x), bearing in mind that 2/2 − 2 > 0.
∂E [t]
∂
= 2
2 − 2
[
( + x − zi)(
 − wz
i
) −1( − wzi )
( + x − zi)2
]
= 2
2 − 2
−1
( + x − zi)
< 0 if ( + x) > zi . (A20.1)
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Table A4
Correlation matrix.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1. Total R&D int. 1.000
2.  Total R&D int. sq. 0.904 1.000
3.  Interaction 1*4 0.735 0.665 1.000
4.  Herﬁndahl index −0.014 −0.003 0.177 1.000
5. Herf. ind. sq. −0.023 −0.010 0.128 0.892 1.000
6. Relative growth −0.169 −0.137 −0.131 −0.004 −0.004 1.000
7.  Fast growth 0.009 0.006 0.005 0.002 0.002 −0.004 1.000
8.  Age −0.163 −0.083 −0.117 −0.007 0.002 −0.020 −0.048 1.000
9.  Age squared −0.140 −0.071 −0.099 0.000 0.003 −0.020 −0.040 0.964 1.000
10.  Employment −0.023 −0.011 −0.013 0.047 0.037 0.005 −0.007 0.067 0.065 1.000
11.  Empl. sq. −0.003 −0.002 −0.001 0.024 0.019 −0.001 −0.001 0.010 0.009 0.869 1.000
12.  Local units −0.012 −0.006 −0.008 0.025 0.021 0.001 −0.003 0.029 0.027 0.532 0.513 1.000
13.  Deﬂated turnover −0.010 −0.004 −0.007 0.011 0.005 0.016 0.000 0.008 0.007 0.000 0.000 0.000 1.000
14.  Civil R&D ﬁrm −0.079 −0.030 −0.028 0.106 0.071 0.018 −0.015 0.120 0.110 0.060 0.013 0.029 0.000 1.000
15.  UK-owned ﬁrm 0.055 0.026 0.038 0.001 0.000 −0.006 0.020 −0.126 −0.108 −0.061 0.001 −0.011 −0.029 −0.088 1.000
16.  Med. Ind. R&D int. 0.372 0.179 0.285 −0.046 −0.059 0.004 0.029 −0.268 −0.240 −0.038 −0.003 −0.015 −0.014 −0.253 0.082 1.000
17.  Pavitt class 1 0.263 0.120 0.181 −0.063 −0.069 0.007 0.019 −0.195 −0.179 −0.020 0.009 −0.003 −0.014 −0.187 0.041 0.689 1.000
18.  Pavitt class 2 −0.059 −0.030 −0.066 −0.113 −0.072 −0.002 0.001 0.002 0.000 −0.010 −0.004 −0.008 −0.006 −0.163 0.023 −0.184 −0.381 1.000
19.  Pavitt class 3 −0.064 −0.028 −0.029 0.131 0.107 0.003 −0.011 0.081 0.067 0.021 −0.002 0.001 0.009 0.103 −0.079 −0.165 −0.234 −0.172 1.000
20.  Pavitt class 4 −0.166 −0.073 −0.116 −0.014 −0.017 −0.007 −0.013 0.174 0.168 0.006 −0.004 0.003 0.014 0.229 −0.036 −0.400 −0.448 −0.330 −0.202 1.000
21.  Pavitt class 5 −0.028 −0.016 0.010 0.180 0.158 −0.001 0.000 −0.042 −0.040 0.021 0.000 0.011 0.000 0.094 0.043 −0.090 −0.190 −0.140 −0.086 −0.164 1.000
22.  Av. Eff. Exch. Rate 0.001 −0.005 −0.029 −0.088 −0.052 −0.006 0.028 −0.167 −0.189 0.020 0.004 0.008 −0.008 0.149 −0.014 −0.003 0.064 −0.037 0.015 −0.034 −0.018 1.000
23.  Crisis dummy  0.019 0.012 0.004 −0.008 −0.004 0.004 0.000 −0.061 −0.066 0.008 0.003 0.001 −0.003 −0.053 −0.020 0.049 0.042 −0.016 0.010 −0.022 −0.025 0.131 1.000
24.  Lending premium 0.034 0.017 0.006 −0.028 −0.012 0.008 −0.013 −0.083 −0.085 0.015 0.006 0.000 −0.002 −0.078 −0.032 0.104 0.053 −0.015 0.012 −0.036 −0.027 0.064 0.761 1.000
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Fig. A2. Cox-Snell residual plots for log-normal and comparator models.
Note: The Cox-Snell residuals are conditional on the covariate vector. The Nelson-Aalen cumulative hazard function is compared with the diagonal line. If the hazard function
follows  the 45◦ line, the model ﬁts the data well. Only the log-normal model (top-left corner) satisﬁes this condition. Deviations from the 45◦ line at large values of time are
to  be expected (Cleves et al., 2008).
Similarly,
∂E [t]
∂x
= 2
2 − 2
[
( + x − zi)(
 − wz
i
) −1( − wzi )
( + x − zi)2
]
= 2
2 − 2
−1
( + x − zi)
< 0 if ( + x) > zi . (A20.2)
Results in Eqs. (A20.1) and (A20.2) indicate that an increase in
the discount rate or in the rate of creative destruction is associ-
ated with a reduction in survival time – provided that the ﬁrm’s
innovation intensity is less than the sum of two rates.
Finally, it can also be shown that an increase in the discount rate
or in the rate of creative destruction is associated with a reduction
in the normalised value of the production line. From Eq. (A3), we
can write:
∂v
∂
=
−1
(
 − wz
i
)
( + x − zi)2
= −
(
 − wz
i
)
( + x − zi)2
< 0 if  − wz
i
> 0 (A21.1)
∂v
∂x
=
−1
(
 − wz
i
)
( + x − zi)2
= −
(
 − wz
i
)
( + x − zi)2
< 0 if  − wz
i
> 0 (A21.2)
Results in Eqs. (A21.1) and (A21.2) indicate that an increase in
the discount rate or the rate of creative destruction is associated
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with a decrease in the normalised value of the knowledge produc-
tion line − provided that the adjusted proﬁts are positive.
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